perinal


"It is impossible to understand addiction without asking what relief the addict finds, or hopes to find, in the drug or the addictive behavior."
- Gabor Maté

Perinatal substance use and abuse: Resources

Primary Prevention

Development of these materials was funded by the Cooperative Agreement 6 NU17CE002741-03-01 Centers for Disease Control and Prevention (CDC).
The content of the materials does not necessarily represent the official views of the CDC or the U.S. Department of Health and Human Services.

For Opioid Use Disorder Treatment Providers

These materials were developed to support MAT providers in their work with women of reproductive age. The materials are united by the theme, Protect, Plan, Prepare.
  • Protect, Plan, Prepare poster. The poster promotes the message in a soothing visual display. The poster can be printed in either 8.5x11 in. or 11x14 in. sizes.
  • Protect, Plan, Prepare take away card. The card, designed to be folded in half to business card size, promotes the message in a format suitable for easy dissemination. Click here to download a PDF of the card. The image measures 4.6x3.8 in. and includes crop marks for printing.
  • Protect, Plan, Prepare patient questionnaire. The questionnaire is designed to frame reproductive planning in the context of a woman's visit with a medication-assisted treatment provider. Click here to download a PDF of the questionnaire.

For Primary Care Providers

COMING SOON
  • Patient Education Poster. The poster, intended for use in a range of primary care settings, will be available for download and printing in two sizes, 8.5x11 in and 11x14 in.
  • Patient Discharge Information Menu. This document is intended for use in an electronic health record. Providers will be able to select the sections relevant for discharge to include in the discharge instructions.
  • Provider Education Handout. This document is intended for use in clinical or other provider educational settings. It will raise awareness and offer key practice recommendations and resources at the point of care.
  • Population Health and Quality Improvement "Starter Kit". This document highlights opportunities to participate in quality improvement efforts related to primary prevention.

From Just Say No to Just Say Know (and Do)

From Just Say No to Just Say Know (and Do)
This document was developed to describe a framework for comprehensive care of women with opioid use disorder. It is intended for stakeholders committed to improving the care for women with opioid use disorder.

Medication Chart

Medication Chart (Opioids, Benzodiazepines, Other)
This medication chart lists maternal and fetal/neonatal risks and reported side effects in breastfed infants of commonly used medications. For information on antidepressants, see the companion chart by clicking here.

Legal Issues Related to Screening

Amanda Leipold, JD, MPH, discusses the legal requirements related to screening women and infants.

Community Resources

2016 Opioid Webinar Presentations

To access the archived recordings, please go to the Online Classroom.

One Day at a Time: Counseling Women Affected by Opioids (March 9)

Authorization to Use and Disclose Health Information

Authorization to Use and Disclose Health Information
This authorization template was designed to facilitate communication between obstetric care providers and opioid treatment centers. This authorization complies with HIPAA, Wisconsin law, and federal law 42 CFR Part 2 (governing the use and disclosure of alcohol and drug abuse treatment records).

A Blueprint for Action: Improving Care for Women and Infants Affected by Opioids

A Blueprint for Action: Improving Care for Women and Infants Affected by Opioids
The blueprint is a document from which stakeholders can collaborate and coordinate efforts to improve care for women and infants affected by opioids. It identifies six areas for change that are intended to focus on major areas that can improve care of women and infants and lead to better outcomes.

Newborn Withdrawal Project Educational Toolkit

This compendium of educational materials is intended for both parents and health care providers of newborns experiencing neonatal abstinence syndrome (NAS) and pregnant women undergoing methadone maintenance treatment (MMT) or other treatments for opioid addiction.

 

Assessment and Intervention in the Home: Women and Infants Affected by Opioids

Assessment and Intervention in the Home: Women and Infants Affected by Opioids: This tool is intended for anyone who may provide care in the home to women or infants affected by opioids.

 

FAQs for families

Opioid FAQs: The WAPC Infant and Family Committee developed these consumer-oriented FAQs to complement the Newborn Withdrawal Project Educational Toolkit.

 

Salena's Story

Salena's Story: This video tells the story of a young mother struggling with opioid addiction. In her own words, Salena shares her experience with addiction throughout her two pregnancies, recounting her journey from shame and fear to hope and courage. 

 

Smoking Cessation Magnet

Smoking Cessation Magnet design: The Southeast Region developed this design to be used on refrigerator magnets. It's available to you to use for producing magnets or printed on card stock to be distributed. Available in English and Spanish as a free download.

 

General Information from the AAP and ACOG on NAS and opioids in pregnancy

Protocols for managing infants with Neonatal Abstinence Syndrome

The evidence base for supporting one protocol over another is lacking at this time. The protocols below are intended to serve as  examples for consideration.

 

Protocols for managing pregnant women on opioids

The evidence base for supporting one protocol over another is lacking at this time. The protocols below are intended to serve as examples for consideration.